Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/87S stock hub

FRA/87S has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/87Sis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

17.4B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/87S

In the news

Latest news · FRA/87S

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-19.1

P25 n/aP50 n/aP75 n/a

ROIC-238

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/87S market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

153

Groups with data

Currency

USD

Showing 153 of 153 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Bermuda
Country code	DE
Employees	750
Employees Change	-158%
Employees Change Percent	-17.4
Enterprise value	EUR 14.2B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 17.4B
Price	EUR 23.85
Price currency	EUR
Rev Per Employee	15,114.84x
Sic	2836
Symbol	fra/87S
Website	https://roivant.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.97%
EV Earnings	-20.62x
EV/FCF	-21.76x
FCF yield	-3.76%
P/B ratio	4.1x
P/S ratio	1,531.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -523.5M
Net Income	EUR -689.2M
Pretax Margin	-6,925.09%
Profit Per Employee	EUR -918,973
ROA	-14.47
Roa5y	-14.63
ROCE	-25.14
ROE	-19.14
Roe5y	-7.23
ROIC	-238
Roic5y	-342.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	145.42%
Cagr3y	48.37%
Revenue Growth	-56.37x
Revenue Growth Q	-77.83x
Revenue Growth3 Y	-32.42x
Revenue Growth5 Y	-28.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0
Assets	EUR 4.5B
Cash	EUR 3.9B
Current Assets	EUR 4B
Current Liabilities	EUR 128.9M
Debt	EUR 92.8M
Debt Equity	EUR 0.02
Debt FCF	EUR -0.14
Equity	EUR 4.2B
Liabilities	EUR 213.9M
Long Term Assets	EUR 499M
Long Term Liabilities	EUR 85M
Net Cash	EUR 3.8B
Net Cash By Market Cap	EUR 21.68
Net Cash Growth	-12.39%
Net Debt Equity	EUR -0.89
Tangible Book Value	EUR 3.6B
Tangible Book Value Per Share	EUR 5.12

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	30.66
Net Working Capital	EUR -9.9M
Quick ratio	29.81
Working Capital	EUR 3.8B
Working Capital Turnover	EUR 0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	7.7%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	145.27%
200-day SMA	17.51
3Y total return	226.71%
50-day SMA	24.11
50-day SMA vs 200-day SMA	50over200
All Time High	25.72
All Time High Change	-7.27%
All Time High Date	2026-03-11
All Time Low	2.56
All Time Low Change	831.64%
All Time Low Date	2022-05-12
ATR	0.44
Ch YTD	31.3
High	23.88
High52	25.72
High52 Date	2026-03-11
High52ch	-7.27%
Low	23.85
Low52	8.98
Low52 Date	2025-07-08
Low52ch	165.53%
Ma50ch	-1.06%
Price vs 200-day SMA	36.18%
RSI	49.48
RSI Monthly	81.31
RSI Weekly	70.43
Sharpe ratio	2.39x
Sortino ratio	4.37
Total Return	7.7%
Tr YTD	31.3
Tr1m	0.34%
Tr1w	1.02%
Tr3m	17.49%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -1.1B
Operating margin	-9,581.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	542,023,758%
Shares Insiders	24.23%
Shares Institutions	72.28%
Shares Qo Q	2.34%
Shares Yo Y	-7.7%
Short Ratio	4.46

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -953.3M
Average Volume	3.5x
Bv Per Share	5.12
CAPEX	EUR -6.6M
Ch1m	0.34
Ch1w	1.02
Ch1y	145.3
Ch3m	17.49
Ch3y	226.7
Ch6m	38.95
Change	-1.57%
Change From Open	-0.13
Close	24.23
Days Gap	-1.44
Depreciation Amortization	9,220,738.8
Earnings Date	2026-05-29
EBIT	EUR -1.1B
EBITDA	EUR -1.1B
EPS	EUR -1
F Score	1
FCF	EUR -653.1M
FCF EV Yield	-4.6x
Financing CF	22,024,962
Fiscal Year End	March
Founded	2,014
Income Tax	EUR 71.8M
Investing CF	185,985,729
Is Primary Listing	0
Last Report Date	2025-12-31
Ma150	19.84
Ma150ch	20.21%
Ma20	24.08
Ma20ch	-0.95%
Net CF	-436,840,337
Next Earnings Date	2026-05-29
Open	23.88
Position In Range	0
Ppne	82,259,097.7
Price Date	2026-05-08
Ptbv Ratio	4.78
Relative Volume	5.71x
Revenue	11,336,127x
SBC By Revenue	2,648.26x
Share Based Comp	300,210,623
Tax By Revenue	633.34x
Tr6m	38.95%
Z Score	22.54

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/87S pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/87S stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/87S?

Insider, institutional, and short-interest positioning.

Institutional ownership

+72.3%

Share of float held by funds and institutions

Insider ownership

+24.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/87S momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.5

Neutral momentum band

Price vs 200-day MA

+36.2%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

2.39

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/87S

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/87S stock rating?

fra/87S is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/87S analysis?

The full report lives at /stocks/fra/87S/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/87S?

The latest report frames fra/87S around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/87S page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.